# EDGAR Filing Document

**Accession Number:** 0001004724
**File Stem:** 0001493152-23-004647
**Filing Date:** 2023-2
**Character Count:** 29833
**Document Hash:** 36a4bd049e9a86038bd94d8c9c04f29c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-004647.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001493152-23-004647

**CONFORMED SUBMISSION TYPE**: SC TO-I

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** REGIONAL HEALTH PROPERTIES, INC
- **CENTRAL INDEX KEY:** 0001004724
- **STANDARD INDUSTRIAL CLASSIFICATION:** LESSORS OF REAL PROPERTY, NEC [6519]
- **IRS NUMBER:** 815166048
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13E3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-83967
- **FILM NUMBER:** 23623379

**BUSINESS ADDRESS:**
- **STREET 1:** 454 SATELLITE BLVD
- **STREET 2:** SUITE 100
- **CITY:** SUWANEE
- **STATE:** GA
- **ZIP:** 30024
- **BUSINESS PHONE:** 678-869-5116

**MAIL ADDRESS:**
- **STREET 1:** 454 SATELLITE BLVD
- **STREET 2:** SUITE 100
- **CITY:** SUWANEE
- **STATE:** GA
- **ZIP:** 30024

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADCARE HEALTH SYSTEMS, INC
- **DATE OF NAME CHANGE:** 20130530

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADCARE HEALTH SYSTEMS INC
- **DATE OF NAME CHANGE:** 19951208
**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** REGIONAL HEALTH PROPERTIES, INC
- **CENTRAL INDEX KEY:** 0001004724
- **STANDARD INDUSTRIAL CLASSIFICATION:** LESSORS OF REAL PROPERTY, NEC [6519]
- **IRS NUMBER:** 815166048
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-83967
- **FILM NUMBER:** 23623378

**BUSINESS ADDRESS:**
- **STREET 1:** 454 SATELLITE BLVD
- **STREET 2:** SUITE 100
- **CITY:** SUWANEE
- **STATE:** GA
- **ZIP:** 30024
- **BUSINESS PHONE:** 678-869-5116

**MAIL ADDRESS:**
- **STREET 1:** 454 SATELLITE BLVD
- **STREET 2:** SUITE 100
- **CITY:** SUWANEE
- **STATE:** GA
- **ZIP:** 30024

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADCARE HEALTH SYSTEMS, INC
- **DATE OF NAME CHANGE:** 20130530

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADCARE HEALTH SYSTEMS INC
- **DATE OF NAME CHANGE:** 19951208
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** REGIONAL HEALTH PROPERTIES, INC
- **CENTRAL INDEX KEY:** 0001004724
- **STANDARD INDUSTRIAL CLASSIFICATION:** LESSORS OF REAL PROPERTY, NEC [6519]
- **IRS NUMBER:** 815166048
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I

**BUSINESS ADDRESS:**
- **STREET 1:** 454 SATELLITE BLVD
- **STREET 2:** SUITE 100
- **CITY:** SUWANEE
- **STATE:** GA
- **ZIP:** 30024
- **BUSINESS PHONE:** 678-869-5116

**MAIL ADDRESS:**
- **STREET 1:** 454 SATELLITE BLVD
- **STREET 2:** SUITE 100
- **CITY:** SUWANEE
- **STATE:** GA
- **ZIP:** 30024

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADCARE HEALTH SYSTEMS, INC
- **DATE OF NAME CHANGE:** 20130530

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADCARE HEALTH SYSTEMS INC
- **DATE OF NAME CHANGE:** 19951208

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE TO**

**Tender Offer Statement under Section 14(d)(1) or 13(e)(1)**

**of the Securities Exchange Act of 1934**

**REGIONAL HEALTH PROPERTIES, INC.**

**(Name of Subject Company and Filing Person (Issuer))**

**10.875% Series A Cumulative Redeemable Preferred Shares**

**(Title of Class of Securities)**

**75903M200**

**(CUSIP Number of Class of Securities)**

**SCHEDULE 13E-3**

**Rule 13e-3 Transaction Statement under Section 13(e)**

**of the Securities Exchange Act of 1934**

**REGIONAL HEALTH PROPERTIES, INC.**

**(Name of the Issuer and Person Filing Statement)**

**10.875% Series A Cumulative Redeemable Preferred Shares**

**(Title of Class of Securities)**

**75903M200**

**(CUSIP Number of Class of Securities)**

**Brent Morrison**

**Chief Executive Officer and President**

**Regional Health Properties, Inc.**

**454 Satellite Boulevard NW, Suite 100**

**Suwanee, Georgia 30024 (678) 869-5116**

**(Name, address and telephone number of person authorized to receive notices and communications on behalf of filing person)**

***Copies to:***

 ****

**Joshua Davidson**

**Clinton W. Rancher**

**Baker Botts L.L.P.**

**910 Louisiana Street**

**Houston, Texas 77002**

**(713) 229-1234**

☒ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

☐ third-party tender offer subject to Rule 14d-1.

☒ issuer tender offer subject to Rule 13e-4.

☒ going-private transaction subject to Rule 13e-3.

☐ amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐

If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:

☐ Rule 13e-4(i) (Cross-Border Issuer Tender Offer)

☐ Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)

**SCHEDULE TO/13E-3**

This Tender Offer Statement and Rule 13e-3 Transaction Statement on Schedule TO (this "**Schedule TO**") relates to the offer (the "**Exchange Offer**") by Regional Health Properties, Inc. (the "**Company**") to exchange any and all outstanding shares of the Company's 10.875% Series A Cumulative Redeemable Preferred Shares (the "**Series A Preferred Stock**") tendered in the Exchange Offer for newly issued shares of the Company's 12.5% Series B Cumulative Redeemable Preferred Shares (the "**Series B Preferred Stock**").

In exchange for each share of Series A Preferred Stock properly tendered (and not validly withdrawn) prior to 11:59 p.m., New York City time, on , 2023 (such time and date, as the same may be extended, the "**Expiration Date**") and accepted by the Company, participating holders of Series A Preferred Stock will receive one share of Series B Preferred Stock (the "**Exchange Consideration**"). The Exchange Offer will commence on , 2023 and expire at the Expiration Date, unless extended or earlier terminated by us. The Exchange Offer will be made upon the terms and subject to the conditions set forth in the preliminary proxy statement/prospectus (as it may be supplemented and amended from time to time, the "**Prospectus**"), which is filed as exhibit (a)(1)(i) hereto, and in the related letter of transmittal (as it may be supplemented and amended from time to time, the "**Letter of Transmittal**" and, together with the Prospectus, the "**Offering Documents**"), which will be filed by amendment as exhibit (a)(1)(ii) hereto.

This Schedule TO is being filed in satisfaction of the reporting requirements of Rules 13e-3 and 13e-4 promulgated under the Securities Exchange Act of 1934, as amended (the "**Exchange Act**"). Information set forth in the Offering Documents is incorporated herein by reference in response to Items 1 through 13 of this Schedule TO, except those items as to which information is specifically provided herein.

**The Exchange Offer to the holders of the Series A Preferred Stock has not commenced.** 

**Item 1. *Summary Term Sheet.***

The information set forth in the Prospectus in the sections titled "Questions and Answers About the Exchange Offer and the Special Meeting" and "Summary—Summary Terms of the Exchange Offer" is incorporated herein by reference.

**Item 2. *Subject Company Information.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Name and Address.**

The name of the subject company and the filing person is Regional Health Properties, Inc. The address of its principal executive offices is 454 Satellite Boulevard NW, Suite 100, Suwanee, Georgia 30024. Its telephone number is (678) 869-5116.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) Securities.**

The subject class of securities is the Company's 10.875% Series A Cumulative Redeemable Preferred Shares. There are 2,811,535 shares of Series A Preferred Stock issued and outstanding as of the date hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(c) Trading Market and Price.**

The information set forth in the Prospectus in the section titled "Market Price for the Series A Preferred Stock" is incorporated herein by reference.

**Item 3. *Identity and Background of Filing Person.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Name and Address.**

Regional Health Properties, Inc. is the filing person and subject company. The business address and telephone number of the Company are set forth under Item 2(a) of this Schedule TO and are incorporated herein by reference.

**Item 4. *Terms of the Transaction.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Material Terms.**

The information set forth in the Prospectus in the sections titled "Questions and Answers About the Exchange Offer and the Special Meeting," "Summary—Summary Terms of the Exchange Offer," "Risk Factors," "The Exchange Offer," "Description of Capital Stock" and "Material U.S. Federal Income Tax Considerations," as well as the information set forth in the Letter of Transmittal, is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) Purchases.**

The information set forth in the Prospectus in the sections titled "Stock Ownership—Ownership of the Series A Preferred Stock," "Questions and Answers About the Exchange Offer and the Special Meeting," "Summary—Summary Terms of the Exchange Offer" and "The Exchange Offer" is incorporated herein by reference.

**Item 5. *Past Contacts, Transactions, Negotiations and Agreements.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(e) Agreements Involving the Subject Company's Securities.**

The terms of the Company's common stock, no par value per share (the "**Common Stock**"), and Series A Preferred Stock are governed by the Company's Amended and Restated Articles of Incorporation and filed as exhibit (d)(1) hereto.

The information set forth in the Prospectus in the sections titled "Description of Capital Stock," "Executive Compensation" and "Director Compensation" is incorporated herein by reference.

**Item 6. *Purposes of the Transaction and Plans or Proposals.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Purposes.**

The information set forth in the Prospectus in the sections titled "Questions and Answers About the Exchange Offer and the Special Meeting," "Special Factors—Background of the Exchange Offer" and "The Exchange Offer—Reasons for the Exchange Offer" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) Use of Securities Acquired.**

Shares of Series A Preferred Stock accepted for exchange by the Company in the Exchange Offer will be cancelled.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(c) Plans.**

(1) The
 information set forth in the Prospectus in the sections titled "Special Factors—Background
 of the Exchange Offer," "The Exchange Offer—Reasons for the Exchange Offer"
 and "The Exchange Offer— Consequences of Failure to Exchange Series A Preferred
 Stock in the Exchange Offer" is incorporated herein by reference.

(2) The
 information set forth in the Prospectus in the sections titled "Special Factors—Background
 of the Exchange Offer," "The Exchange Offer—Reasons for the Exchange Offer"
 and "The Exchange Offer— Consequences of Failure to Exchange Series A Preferred
 Stock in the Exchange Offer" is incorporated herein by reference.

(3) The
 information set forth in the Prospectus in the sections titled "Special Factors—Background
 of the Exchange Offer," "The Exchange Offer—Reasons for the Exchange Offer,"
 "The Exchange Offer— Consequences of Failure to Exchange Series A Preferred Stock
 in the Exchange Offer" and "Dividend Policy and Dividends Paid on Our Common
 Stock" is incorporated herein by reference.

(4) None.

(5) The
 information set forth in the Prospectus in the sections titled "Special Factors—Background
 of the Exchange Offer," "The Exchange Offer—Reasons for the Exchange Offer"
 and "The Exchange Offer— Consequences of Failure to Exchange Series A Preferred
 Stock in the Exchange Offer" is incorporated herein by reference.

(6) The
 Company believes that the Exchange Offer has a reasonable likelihood of causing the Series
 A Preferred Stock to be delisted from the NYSE American LLC (the "**NYSE American** ").

(7) The
 Company believes that the Exchange Offer has a reasonable likelihood of causing the Series
 A Preferred Stock to be eligible for termination of registration under Section 12(g)(4) of
 the Exchange Act.

(8) None.

(9) The
 information set forth in the Prospectus in the sections titled "Special Factors—Background
 of the Exchange Offer," "The Exchange Offer—Reasons for the Exchange Offer,"
 "The Exchange Offer— Conditions of the Exchange Offer" and "Capitalization"
 is incorporated herein by reference.

(10) None.

**Item 7. *Source and Amount of Funds or Other Consideration.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Source of Funds.**

The information set forth in the Prospectus in the sections titled "Questions and Answers About the Exchange Offer and the Special Meeting" and "The Exchange Offer—Terms of the Exchange Offer" is incorporated herein by reference. Assuming full participation in the Exchange Offer, the Company will issue approximately 2,811,535 shares of Series B Preferred Stock as consideration for the Exchange Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) Conditions.**

The information set forth in the Prospectus in the sections titled "Questions and Answers About the Exchange Offer and the Special Meeting," "The Exchange Offer—Terms of the Exchange Offer" and "The Exchange Offer—Conditions of the Exchange Offer" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(d) Borrowed Funds.**

Not applicable.

**Item 8. *Interest in the Securities of the Subject Company.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Securities Ownership.**

The information set forth in the Prospectus in the section titled "Stock Ownership—Ownership of the Series A Preferred Stock" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) Securities Transactions.**

None.

**Item 9. *Persons/Assets, Retained, Employed, Compensated or Used.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Solicitations or Recommendations.**

The information set forth in the Prospectus in the sections titled "The Exchange Offer" and "The Special Meeting—Proxy Solicitor and Information Agent" is incorporated herein by reference. None of the Company, its Board of Directors, officers or employees, the information agent, the exchange agent, the proxy solicitor, any of the Company's financial advisors nor any other person is making any recommendation to any holder of Series A Preferred Stock as to whether or not such holder should tender their shares of Series A Preferred Stock in the Exchange Offer.

**Item 10. *Financial Statements.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Financial Information.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The financial statements
set forth in the Prospectus in "Annex C-1" under "Part II, Item 8" are incorporated herein by reference.

(2) The financial statements
set forth in the Prospectus in "Annex C-2" under "Part I, Item 1" are incorporated herein by reference.

(3) The financial statements
set forth in the Prospectus in "Annex C-3" under "Part I, Item 1" are incorporated herein by reference.

(4) The financial statements
set forth in the Prospectus in "Annex C-4" under "Part I, Item 1" are incorporated herein by reference.

(5) The book value
per share of the Common Stock as of September 30, 2022 was -$32.12.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) Pro Forma Information.**

Not applicable.

**Item 11. *Additional Information.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) Agreements, Regulatory Requirements and Legal Proceedings.**

The information set forth in the Prospectus in the section titled "The Exchange Offer—Conditions of the Exchange Offer" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(c) Other Material Information.**

The information set forth in the Prospectus and the Letter of Transmittal is incorporated herein by reference.

**Item 12. *Exhibits.***

**<u> </u>**

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| (a)(1)(i) | [Preliminary Proxy Statement/Prospectus, dated February 14, 2023 (the "Prospectus") (incorporated by reference to the Company's Registration Statement on Form S-4 (Reg. No. 333-269750) filed on February 14, 2023).](https://www.sec.gov/Archives/edgar/data/1004724/000149315223004597/forms-4.htm) |
| (a)(1)(ii)\* | Letter of Transmittal. |
| (a)(1)(iii)\* | Notice of Guaranteed Delivery. |
| (a)(4) | [The Prospectus (see Exhibit (a)(1)(i)).](https://www.sec.gov/ix?doc=/Archives/edgar/data/1004724/000149315223004597/forms-4.htm) |
| (a)(5)(i) | [Form of Amended and Restated Article III of the Amended and Restated Articles of Incorporation of Regional Health Properties, Inc. (included as Annex A to the Prospectus, see Exhibit (a)(1)(i)).](https://www.sec.gov/Archives/edgar/data/1004724/000149315223004597/forms-4.htm#thi_009) |
| (a)(5)(ii) | [Form of Amended and Restated Section 2.1 of the Amended and Restated Articles of Incorporation of Regional Health Properties, Inc. (included as Annex B-1 to the Prospectus, see Exhibit (a)(1)(i)).](https://www.sec.gov/Archives/edgar/data/1004724/000149315223004597/forms-4.htm#thi_010) |
| (a)(5)(iii) | [Form of Article X of the Amended and Restated Articles of Incorporation of Regional Health Properties, Inc. (included as Annex B-2 to the Prospectus, see Exhibit (a)(1)(i)).](https://www.sec.gov/Archives/edgar/data/1004724/000149315223004597/forms-4.htm#thi_012) |
| (a)(5)(iv) | [The Company's Annual Report on Form 10-K for the year ended December 31, 2021 (incorporated by reference to the Company's Annual Report on Form 10-K for the year ended December 31, 2021 filed on February 22, 2022).](https://www.sec.gov/ix?doc=/Archives/edgar/data/1004724/000156459022005755/rhe-10k_20211231.htm) |
| (b) | Not applicable. |
| (d)(1) | [Amended and Restated Articles of Incorporation of Regional Health Properties, Inc. (incorporated by reference to Exhibit 3.1 of the Company's Current Report on Form 8-K12B filed on October 2, 2017).](https://www.sec.gov/Archives/edgar/data/1004724/000100472417000056/copyof31rheamendedandresta.htm) |
| (d)(2) | [Regional Health Properties, Inc. 2020 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 of the Company's Current Report on Form 8-K filed on December 17, 2020).](https://www.sec.gov/Archives/edgar/data/1004724/000156459020057438/rhe-ex991_30.htm) |
| (g) | Not applicable. |
| (h)\* | Tax Opinion of Baker Botts L.L.P. |
| 107 | [Filing Fee Table.](ex107.htm) |

---

\* To be filed by amendment.

**Item 13. *Information Required by Schedule 13E-3.***

The following sets forth the information required by Schedule 13E-3 that has not already been set forth in Items 1-12 above. The information set forth in the Prospectus is incorporated herein by reference to the items required by Schedule 13E-3.

**Item 2 of Schedule 13E-3. *Subject Company Information*.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The
 information set forth in the Prospectus in the sections titled "Questions and Answers
 About the Exchange Offer and the Special Meeting," "Special Factors—Background
 of the Exchange Offer" and "Dividend Policy and Dividends Paid on Our Common
 Stock" is incorporated herein by reference.

(e) None.

(f) None.

**Item 3 of Schedule 13E-3. *Identity and Background of the Filing Person*.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) None.

(c) None.

**Item 4 of Schedule 13E-3. *Terms of the Transaction*.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The
 information set forth in the Prospectus in the sections titled "Questions and Answers
 About the Exchange Offer and the Special Meeting," "Summary—Summary Terms
 of the Exchange Offer," "The Exchange Offer—Terms of the Exchange Offer"
 and "The Exchange Offer—No Appraisal Rights" is incorporated herein by
 reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) The
 Series B Preferred Stock offered as part of the Exchange Consideration has no established
 trading market. The Company intends to apply for the listing of shares of the Series B Preferred
 Stock on the NYSE American, and, if listed, the Company expects that the shares of Series
 B Preferred Stock will trade under the ticker symbol "RHE PRB."

**Item 5 of Schedule 13E-3. *Past Contracts, Transactions, Negotiations and Agreements*.**

---

| | |
|:---|:---|
| (a)(1) | None. |
| (a)(2) | The information set forth in the Prospectus in the sections titled "Description of Capital Stock," "Executive Compensation" and "Director Compensation" is incorporated herein by reference. |
| (b)(1) | None. |
| (b)(2) | None. |
| (b)(3) | None. |
| (b)(4) | The information set forth in the Prospectus in the section titled "Special Factors—Background of the Exchange Offer" is incorporated herein by reference. |
| (b)(5) | The information set forth in the Prospectus in the section titled "Special Factors—Background of the Exchange Offer" is incorporated herein by reference. |
| (b)(6) | The information set forth in the Prospectus in the sections titled "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Description of Business" is incorporated herein by reference. |
| (c) | The information set forth in the Prospectus in the sections titled "Special Factors—Background of the Exchange Offer," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Description of Business" is incorporated herein by reference. |

---

**Item 7 of Schedule 13E-3. *Purposes, Alternatives, Reasons and Effects*.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 information set forth in the Prospectus in the sections titled "Questions and Answers
 About the Exchange Offer and the Special Meeting," "Special Factors—Background
 of the Exchange Offer," "Special Factors—Business Considerations by the
 Board of Directors" and "The Exchange Offer—Reasons for the Exchange Offer"
 is incorporated herein by reference.

(c) The
 information set forth in the Prospectus in the sections titled "Questions and Answers
 About the Exchange Offer and the Special Meeting," "Special Factors—Background
 of the Exchange Offer," "Special Factors—Business Considerations by the
 Board of Directors" and "The Exchange Offer—Reasons for the Exchange Offer"
 is incorporated herein by reference.

(d) The
 information set forth in the Prospectus in the sections titled "Questions and Answers
 About the Exchange Offer and the Special Meeting," "Summary—Summary Terms
 of the Exchange Offer," "Special Factors—Business Considerations by the
 Board of Directors," "The Exchange Offer" and "Material U.S. Federal
 Income Tax Considerations" is incorporated herein by reference.

**Item 8 of Schedule 13E-3. *Fairness of the Transaction*.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 information set forth in the Prospectus in the section titled "Special Factors—Determination
 of Fairness of the Exchange Offer by the Company" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 information set forth in the Prospectus in the section titled "Special Factors—Determination
 of Fairness of the Exchange Offer by the Company" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The
 Exchange Offer is not structured so that approval of at least a majority of unaffiliated
 Company shareholders is required. The information set forth in the Prospectus in the sections
 titled "Summary—Summary Terms of the Exchange Offer," "The Exchange
 Offer—Conditions of the Exchange Offer," "The Special Meeting—Record
 Date and Voting Rights," "The Special Meeting—Quorum and Counting of Votes,"
 "Preferred Series A Charter Amendment Proposal— Vote Required," "Series
 B Preferred Stock Proposal—Vote Required," "Common Charter Amendment Proposal—Vote
 Required" and "Adjournment Proposal—Vote Required" is incorporated
 herein by reference.

(d) An
 unaffiliated representative was not engaged by the Company to act solely on behalf of the
 unaffiliated holders of Series A Preferred Stock for purposes of negotiating the terms of
 the Exchange Offer. The information set forth in the Prospectus in the sections titled "Risk
 Factors—Risks Related to the Exchange Offer" and "Special Factors—Determination
 of Fairness of the Exchange Offer by the Company" is incorporated herein by reference.

(e) The
 information set forth in the Prospectus in the sections titled "Special Factors—Background
 of the Exchange Offer" and "Special Factors—Determination of Fairness of
 the Exchange Offer by the Company" is incorporated herein by reference.

(f) Not
 applicable.

**Item 9 of Schedule 13E-3. *Reports, Opinions, Appraisals and Negotiations*.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Company has not received any report, opinion or appraisal from an outside party with respect
 to the Exchange Offer. The information set forth in the Prospectus in the sections titled
 "Special Factors—Background of the Exchange Offer" and "Special Factors—Determination
 of Fairness of the Exchange Offer by the Company" is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) None.

**Item 10 of Schedule 13E-3. *Source and Amounts of Funds or Other Consideration*.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The
 information set forth in the Prospectus in the section titled "The Exchange Offer—Fees
 and Expenses" is incorporated herein by reference.

**Item 12 of Schedule 13E-3. *The Solicitation or Recommendation*.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The
 information set forth in the Prospectus in the sections titled "Stock Ownership—Ownership
 of the Series A Preferred Stock," "Questions and Answers About the Exchange Offer
 and the Special Meeting," "Summary—Summary Terms of the Exchange Offer,"
 "The Exchange Offer" and "The Special Meeting—Voting of Proxies"
 is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) None.

**Item 14 of Schedule 13E-3. *Persons/Assets, Retained, Employed, Compensated or Used*.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 information set forth in the Prospectus in the section titled "The Exchange Offer—Fees
 and Expenses" is incorporated herein by reference.

**Item 16 of Schedule 13E-3. *Exhibits*.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) None.

**SIGNATURES**

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| | | |
|:---|:---|:---|
| Date: February 14, 2023 |  |  |
|  | **REGIONAL HEALTH PROPERTIES, INC.** | **REGIONAL HEALTH PROPERTIES, INC.** |
|  | By: | */s/ Brent Morrison* |
|  |  | Brent Morrison |
|  |  | Chief Executive Officer and President |

---

## Ex-Filing

**Exhibit 107**

**Calculation of Filing Fee Tables**

**Schedule TO/13E-3**

(Form Type)

**Regional Health Properties, Inc.**

(Exact Name of Registrant as Specified in its Charter)

<br><u>Table 1: Transaction Valuation</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Transaction**<br>**Valuation** |  | **Fee Rate** | **Amount of**<br>**Filing Fee** |  |
| Fees to Be Paid | $10149641.35 | (1) | 0.00011020 | $1118.49 |  |
| Fees Previously Paid | N/A |  |  | N/A |  |
| **Total Transaction Valuation** | $10149641.35 |  |  |  |  |
| **Total Fees Due for Filing** |  |  |  | $1118.49 |  |
| **Total Fees Previously Paid** |  |  |  |  |  |
| **Total Fee Offsets** |  |  |  | $1118.49 | (2) |
| **Net Fee Due** |  |  |  | $0.00 |  |

---

<u>Table 2: Fee Offset Claims and Sources</u>

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Registrant**<br> **or**<br> **Filer Name** | **Form or**<br> **Filing Type** | **File Number** | **Initial**<br> **Filing Date** | **Filing Date** | **Fee Offset**<br> **Claimed** |  | **Fee Paid**<br> **with**<br> **Fee Offset**<br> **Source** |  |
| Fee Offset <br>Claims |  | S-4 | 333-269750 | 2/14/2023 |  | $1118.49 | (2) |  |  |
| Fee Offset <br>Sources | Regional Health Properties, Inc. | S-4 | 333-269750 |  | 2/14/2023 |  |  | $1118.49 | (2) |

---

(1) Estimated
 solely for the purpose of calculating the filing fee for this transaction in accordance with
 Rule 0-11 of the Securities Exchange Act of 1934, as amended, based on the average of the
 high and low prices of the 10.875% Series A Cumulative Redeemable Preferred Shares, no par
 value per share (the " <u>Series A Preferred Stock</u> "), of Regional Health Properties,
 Inc. (the " <u>Registrant</u> "), as reported on the NYSE American LLC on February
 9, 2023 ($3.61 per share), multiplied by the maximum number of shares of Series A Preferred
 Stock subject to the transaction reported hereby (2,811,535).

(2) The
 Registrant previously paid $1,118.49 upon the initial filing of its Registration Statement
 on Form S-4 on February 14, 2023 in connection with the transaction reported hereby.